Feng Shuyi, Kong Pengxu, Wang Shouzheng, Duan Fujian, Zhang Fengwen, Xie Yongquan, Li Zefu, Li Wenchao, Pan Xiangbin
Department of Structural Heart Disease, National Center for Cardiovascular Disease, China & State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 100037 Beijing, China.
National Health Commission Key Laboratory of Cardiovascular Regeneration Medicine, National Clinical Research Center for Cardiovascular Diseases, 100037 Beijing, China.
Rev Cardiovasc Med. 2023 Dec 12;24(12):346. doi: 10.31083/j.rcm2412346. eCollection 2023 Dec.
Transcatheter edge-to-edge repair (TEER) of the mitral valve has emerged as an alternative treatment for mitral regurgitation (MR). However, the high radiation exposure during the process has been associated with multiple adverse effects for medical staff. In this study, we assessed the feasibility and safety of TEER performed solely under the echocardiographic (echo) guidance.
Between April 2021 to August 2021, we retrospectively collected characteristics of 23 patients with MR who underwent TEER under echocardiographic guidance exclusively. Follow-up evaluations were performed at 1- , 3-months and 1-year post procedure.
All 23 patients (mean age, 66.1 12.1 years; 65.2% males) successfully underwent echo-guided TEER, with 22 patients under transesophageal echo (TEE) guidance and 1 patient under transthoracic echo (TTE) guidance for severe esophageal stenosis. Of the patients, 60.9% received 1 implant and 39.1% received 2 implants. The median total procedural time was 130 (interquartile range, IQR: 90-150) min and the device procedure time was 73 (IQR: 58-100) min. The median length of stay was 6 (IQR: 5-9) days. At 3-months follow-up, 63.6% of patients had an MR 1+ and 90.9% had an MR 2+ ( 0.001 vs. baseline). Improvement in functional status was observed, with 40.9% of patients classified as New York Heart Association (NYHA) functional class I and 45.5% as NYHA functional class II ( 0.001 compared to baseline) at 3-months. At 1-year follow-up, 90.4% maintained MR reduction with MR 2+ ( 0.001 vs. baseline). Single leaflet device attachment (SLDA) occurred in one patient (4.3%) 1-week post procedure.
This retrospective, single-center, and pilot study demonstrates the feasibility, safety, and low complication rates of TEER guided solely by echocardiography. Our findings support the systematic use of echocardiography as the sole guidance modality for TEER, highlighting its potential as an alternative to fluoroscopy-guided procedures. Further multicenter and comparative studies are warranted to confirm these results and provide a more comprehensive evaluation of this approach.
经导管二尖瓣缘对缘修复术(TEER)已成为二尖瓣反流(MR)的一种替代治疗方法。然而,该过程中较高的辐射暴露对医务人员有多种不良影响。在本研究中,我们评估了仅在超声心动图(echo)引导下进行TEER的可行性和安全性。
在2021年4月至2021年8月期间,我们回顾性收集了23例仅在超声心动图引导下接受TEER的MR患者的特征。术后1个月、3个月和1年进行随访评估。
所有23例患者(平均年龄66.1±12.1岁;65.2%为男性)均成功接受了超声心动图引导下的TEER,其中22例在经食管超声心动图(TEE)引导下,1例因严重食管狭窄在经胸超声心动图(TTE)引导下进行。患者中,60.9%植入1个装置,39.1%植入2个装置。总手术时间中位数为130(四分位间距,IQR:90 - 150)分钟,器械操作时间为73(IQR:58 - 100)分钟。住院时间中位数为6(IQR:5 - 9)天。在3个月随访时,63.6%的患者MR≤1+,90.9%的患者MR≤2+(与基线相比,P<0.001)。观察到功能状态有所改善,3个月时40.9%的患者被分类为纽约心脏协会(NYHA)功能I级,45.5%为NYHA功能II级(与基线相比,P<0.001)。在1年随访时,90.4%的患者维持MR减轻,MR≤2+(与基线相比,P<0.001)。1例患者(4.3%)在术后1周发生单叶瓣装置附着(SLDA)。
这项回顾性、单中心的试点研究证明了仅由超声心动图引导的TEER的可行性、安全性和低并发症发生率。我们的研究结果支持将超声心动图作为TEER的唯一引导方式进行系统应用,突出了其作为荧光透视引导手术替代方法的潜力。需要进一步的多中心和对比研究来证实这些结果,并对这种方法进行更全面的评估。